Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Novel DPP IV inhibitors prepared

July 10, 2012

Lupin presents novel GLP-1 receptor modulators

July 10, 2012

New agents for cancer reported by Kasina Laila Innova Pharmaceuticals

July 10, 2012

New MPGES-1 inhibitors designed in Germany

July 10, 2012

Scientists at Actelion Pharmaceuticals patent new FPR2/ALX receptor agonists

July 10, 2012

Boehringer Ingelheim presents novel MPGES-1 inhibitors

July 9, 2012

New candidate cancer therapeutics designed at CSIR

July 9, 2012

Novel FPR2/ALX receptor agonists divulged by Actelion Pharmaceuticals

July 9, 2012

Siena Biotech patents new SMO receptor antagonists

July 9, 2012

Researchers at Piramal Life Sciences prepare new PI3Kalpha inhibitors

July 9, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...